A randomized, double-blind, comparative study of VN-100 in healthy adult Japanese volunteers

DAIICHISANKYO Co.,Ltd.0 个研究点目标入组 600 人开始时间: 2013年3月27日最近更新: 2023年10月17日

试验速览

阶段: 1 期
状态: 已完成
发起方
入组人数: 600

研究概览入排标准研究者记录与标识符相似试验

研究概览

简要总结

As a result of the immunogenicity and safety of VN-100 in healthy adults and elderly, a good increase in antibody titer and safety were confirmed. The immunogenicity of VN-100 with 6 micro g, 9 micro g, and 15 micro g was similar to subcutaneous influenza HA vaccine.

研究设计

研究类型: Interventional

入排标准

年龄范围: >= 20age old 至 ot applicable（—）
性别: All

入选标准

•Healthy adult Japanese volunteers

排除标准

•1) Subjects with history of seasonal influenza in the past 6 months
•2) Subjects with history of seasonal influenza vaccination in the past 6 months

研究者

发起方

DAIICHISANKYO Co.,Ltd.

相似试验

已完成

3 期

VN-100 Ph3 non-inferiority studyProphylaxis of influenza infection

JPRN-jRCT2080222443DAIICHISANKYO Co.,Ltd.901

已完成

3 期

A Study of Live Oral Cholera Vaccine, PXVX200 in Healthy Older AdultsCholera

NCT02100631Bavarian Nordic398

终止

2 期

Study of Visilizumab Versus Placebo in Subjects With Intravenous Steroid-refractory Ulcerative Colitis Previously Responsive in a Visilizumab StudyUlcerative Colitis

NCT00279435Facet Biotech25

已完成

3 期

Study to Assess VPM1002 in Reducing Hospital Admissions and/or Severe Respiratory Infectious Diseases in Elderly in COVID-19 PandemicInfection, Respiratory Tract

NCT04435379Vakzine Projekt Management GmbH2,038

招募中

2 期

Anti-Schistosomiasis Sm14-vaccine in SenegalSchistosomiasis MansoniSchistosomiasis HaematobiumInfection Vaccination

NCT05658614Oswaldo Cruz Foundation120